NTproBNP is not a good prognostic marker in patients with advanced heart failure on ambulatory levosimendan infusion program

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy 1 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by